Free Trial

Healthpeak Properties (NYSE:DOC) Announces FY 2026 Earnings Guidance

Healthpeak Properties logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Healthpeak raised its FY 2026 EPS guidance to $1.76–$1.78, with the $1.77 midpoint matching analyst consensus.
  • Third-quarter revenue increased 16.3% year over year to $820.9 million, while adjusted FFO of $0.44 per share exceeded estimates; however, GAAP EPS of $0.02 significantly missed the $0.43 consensus.
  • Analyst sentiment remains cautious, with four Buy ratings and fourteen Holds producing an overall “Hold” rating and a consensus price target of $21.60. The company also declared a monthly dividend of $0.1017 per share, implying a 6.2% annualized yield.
  • MarketBeat previews top five stocks to own in December.

Healthpeak Properties (NYSE:DOC - Get Free Report) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.760-1.780 for the period, compared to the consensus earnings per share estimate of 1.770.

Analyst Upgrades and Downgrades

A number of analysts recently commented on DOC shares. UBS Group decreased their price objective on Healthpeak Properties from $21.50 to $20.00 and set a "neutral" rating on the stock in a research note on Tuesday, October 13th. Royal Bank Of Canada boosted their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, August 10th. Wells Fargo & Company reduced their target price on shares of Healthpeak Properties from $22.00 to $19.00 and set an "equal weight" rating on the stock in a report on Monday, October 19th. Weiss Ratings cut shares of Healthpeak Properties from a "hold (c+)" rating to a "hold (c)" rating in a research note on Wednesday, September 16th. Finally, Barclays lowered their price target on shares of Healthpeak Properties from $24.00 to $21.00 and set an "equal weight" rating for the company in a report on Tuesday, October 13th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat, Healthpeak Properties has an average rating of "Hold" and a consensus target price of $21.60.

View Our Latest Stock Analysis on DOC

Healthpeak Properties Price Performance

DOC stock opened at $19.54 on Tuesday. Healthpeak Properties has a 52-week low of $15.70 and a 52-week high of $22.95. The stock's fifty day simple moving average is $19.86 and its 200-day simple moving average is $19.15. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. The stock has a market capitalization of $13.47 billion, a price-to-earnings ratio of 10.08, a price-to-earnings-growth ratio of 2.29 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.41). The business had revenue of $820.89 million during the quarter, compared to analyst estimates of $739.18 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business's revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 earnings per share. Equities research analysts expect that Healthpeak Properties will post 1.77 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 18th will be issued a $0.1017 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.22 annualized dividend and a yield of 6.2%. Healthpeak Properties's payout ratio is 348.57%.

Key Healthpeak Properties News

Here are the key news stories impacting Healthpeak Properties this week:

  • Positive Sentiment: Healthpeak reported third-quarter adjusted FFO of $0.44 per share, ahead of the $0.43 analyst consensus, although below $0.46 a year earlier. FFO is a key performance measure for REIT investors. Healthpeak Q3 FFO and Revenues Surpass Estimates
  • Positive Sentiment: The company increased its fiscal 2026 earnings guidance to $1.76-$1.78 per share. The midpoint of $1.77 matches consensus, while the raised outlook signals management remains confident in operating performance. Healthpeak Reports Third Quarter Results and Increases Guidance
  • Positive Sentiment: Revenue rose 16.3% year over year to $820.9 million, and outpatient medical lease executions totaled 846,000 square feet through the quarter, supporting expectations for continued portfolio growth. Healthpeak Q3 Adjusted FFO Falls, Revenue Rises; Lifts 2026 Guidance
  • Neutral Sentiment: Revenue exceeded one reported consensus estimate of $739.2 million but came in below a separate FactSet estimate of $889 million, making the quarter’s top-line performance appear mixed depending on the benchmark. Healthpeak Q3 Revenue Earnings Flash
  • Negative Sentiment: GAAP EPS was just $0.02, substantially below the $0.43 consensus and down from $0.46 a year earlier. The earnings shortfall and lower year-over-year FFO remain risks for investors. Healthpeak Properties Quarterly Earnings

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc NYSE: DOC is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines